{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T19:38:00Z","timestamp":1762025880103,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.neurol.2020.05.006","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T17:40:19Z","timestamp":1596130819000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["An update on epidemiology, diagnosis & management of NMO-SD in the tertiary neurology department of Marrakech (Morocco)"],"prefix":"10.1016","volume":"177","author":[{"given":"N.","family":"Kissani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Cherkaoui Rhazouani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Berrhoute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chraa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Louhab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2020.05.006_bib0080","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2020.05.006_bib0085","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.05.006_bib0090","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.05.006_bib0095","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Annals Neurol"},{"key":"10.1016\/j.neurol.2020.05.006_bib0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.msard.2019.02.012","article-title":"Clinical course of neuromyelitis optica spectrum disorder in a Moroccan cohort","volume":"30","author":"Bennis","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.05.006_bib0105","first-page":"179","article-title":"Neuromyelitis optica spectrum disorders (NMO-SD) in a Sub-Saharan Africa country: a preliminary study of sixteen Senegalese cases","volume":"27","author":"NdiagaMatar","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.05.006_bib0110","first-page":"203","article-title":"lbutt","year":"1870","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2020.05.006_bib0115","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum auto-antibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2020.05.006_bib0120","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0035-3787(05)85192-6","article-title":"Devic's neuromyelitis optica in Morocco. A study of 9 cases","volume":"161","author":"El Otmani","year":"2005","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2020.05.006_bib0125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis spectrum disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.neurol.2020.05.006_bib0130","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.05.006_bib0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: a review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2020.05.006_bib0140","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0074-7742(07)79029-3","article-title":"Neuromyelitis optica: new findings on pathogenesis","volume":"79","author":"Wingerchuk","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.neurol.2020.05.006_bib0145","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.05.006_bib0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2018.01.001","article-title":"Diagnosis and management of neuromyelitis optica spectrum disorders \u2013 an update","volume":"17","author":"Bruscolini","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720306135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720306135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:42:19Z","timestamp":1758519739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378720306135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":15,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0035378720306135"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.05.006","relation":{},"ISSN":["0035-3787"],"issn-type":[{"type":"print","value":"0035-3787"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on epidemiology, diagnosis & management of NMO-SD in the tertiary neurology department of Marrakech (Morocco)","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}